Omada Health CEO Sean Duffy Sells Shares Under Pre-Planned Trading Program
On September 1, 2026, Omada Health (NASDAQ:OMDA) CEO Sean P. Duffy sold 31,457 shares of the company's stock for approximately $735,150 under a pre-established Rule 10b5-1 trading plan. The transaction included both open-market sales and tax-related share withholdings tied to equity vesting. Despite this sale, Duffy still holds over 1.2 million shares directly and indirectly with an estimated value of around $28.63 million as of the date of the transaction. The stock closed at $22.84 on September 1, 2026, reflecting a one-year total return of -4%. Analysts suggest that this insider activity should not be viewed with concern since it was part of an advance trading plan and represents only a small portion of Duffy's overall holdings in the company. Omada Health continues to operate as a profitable digital health platform focused on chronic disease management, serving over one million members through virtual care programs. The CEO transition is expected by January 2027 when Duffy will step down from his role and become Executive Chair.
Tickers: $OMDA
Topics: CEO Rule 10b5-1 plan SEC Form 4 stock sale